[1]
|
Bosch, J. and García-Pagán, J.C. (2000) Complications of Cirrhosis. I. Portal Hypertension. Journal of Hepatology, 32, 141-156. http://dx.doi.org/10.1016/S0168-8278(00)80422-5
|
[2]
|
Arguedas, M.R., Heudebert, G.R., Eloubeidi, M.A., Abrams, G. and Fallon, M.B. (2002) Cost-Effectiveness of Screening, Surveillance, and Primary Prophylaxis Strategies for Esophageal Varices. American Journal of Gastroenterology, 97, 2441-2452. http://dx.doi.org/10.1111/j.1572-0241.2002.06000.x
|
[3]
|
La Mura, V., Reverter, J.C., Flores-Arroyo, A., et al. (2011) Von Willebrand Factor Levels Predict Clinical Outcome in Patients with Cirrhosis and Portal Hypertension. Gut, 60, 1133-1138. http://dx.doi.org/10.1136/gut.2010.235689
|
[4]
|
Sadler, J.E., Mannucci, P.M., Berntorp, E., Bochkov, N., Boulyjenkov, V., Ginsburg, D., et al. (2000) Impact, Diagnosis and Treatment of Von Willebrand Disease. Thrombosis and Haemostasis, 84, 160-174.
|
[5]
|
Reiner, A.P., Siscovick, D.S. and Rosendaal, F.R. (2001) Hemostatic Risk Factors and Ar-terial Thrombotic Disease. Thrombosis and Haemostasis, 85, 584-595.
|
[6]
|
Wanless, I.R., Wong, F., Blendis, L.M., Greig, P., Heathcote, E.J. and Levy, G. (1995) Hepatic and Portal Vein Thrombosis in Cirrhosis: Possible Role in Development of Parenchymal Extinction and Portal Hypertension. Hepatology, 21, 1238-1247.
|
[7]
|
Yilmaz, V.T., Dincer, D., Avci, A.B. and Cetinkaya, R. (2015) Significant Association between Serum Levels of Von Willebrand Factor (vWF) Antigen with Stages of Cirrhosis. Eurasian Journal of Medicine, 47, 21-25. http://dx.doi.org/10.5152/eajm.2014.0016
|
[8]
|
Ferlitsch, M., Reiberger, T., Hoke, M., Salzl, P., Schwengerer, B., Ulbrich, G., Payer, B.A., Trauner, M., Peck-Radosavljevic, M. and Ferlitsch, A. (2012) Von Willebrand Factor as New Noninvasive Predictor of Portal Hypertension, Decompensation and Mortality in Patients With Liver Cirrhosis. Hepatology, 56, 1439-1447. http://dx.doi.org/10.1002/hep.25806
|
[9]
|
Beppu, K., Inokuchi, K., Koyanagi, N., et al. (1981) Prediction of Variceal Haemorrhage by Oesophageal Endoscopy. Gastrointestinal Endoscopy, 27, 213-218. http://dx.doi.org/10.1016/S0016-5107(81)73224-3
|
[10]
|
Paunescu, V., Grigorean, V. and Popescu, C. (2004) Risk Factors for Immediate Outcome of Gastrointestinal Bleeding in Patients with Cirrhosis. Chirurgia [Bucur], 99, 311-322.
|
[11]
|
Mahmoud, H.S., Mostafa, E.F. and Mohammed, M.A. (2014) Role of Portal Haemodynamic Parameters in Prediction of Oesophageal Varices in Cirrhotic Patients. Arab Journal of Gastroenterology, 15, 130-134. http://dx.doi.org/10.1016/j.ajg.2014.09.001
|
[12]
|
Ferro, D., Quintarelli, C., Lattuada, A., Leo, R., Alessandroni, M., Mannucci, P.M., et al. (1996) High Plasma Levels of Von Willebrand Factor as a Marker of Endothelial Perturbation in Cirrhosis: Relationship to Endotoxemia. Hepatology, 23, 1377-1383. http://dx.doi.org/10.1002/hep.510230613
|
[13]
|
Hollestelle, M.J., Geertzen, H.G., Straatsburg, I.H., van Gulik, T.M. and van Mourik, J.A. (2004) Factor VIII Expression in Liver Disease. Thrombosis and Haemostasis, 91, 267-275.
|
[14]
|
Lisman, T., Bongers, T.N., Adelmeijer, J., Janssen, H.L., de Maat, M.P., de Groot, P.G. and Leebeek, F.W. (2006) Elevated Levels of Von Willebrand Factor in Cirrhosis Support Platelet Adhesion despite Reduced Functional Capacity. Hepatology, 44, 53-61. http://dx.doi.org/10.1002/hep.21231
|
[15]
|
Wu, H., Yan, S., Wang, G., Cui, S., Zhang, C. and Zhu, Q. (2015) Von Willebrand Factor as a Novel Noninvasive Predictor of Portal Hypertension and Esophageal Varices in Hepatitis B Patients with Cirrhosis. Scandinavian Journal of Gastroenterology, 16, 1-10. http://dx.doi.org/10.3109/00365521.2015.1037346
|
[16]
|
Ghweil, A.A., Arafa, U.A., Khodeary, A. and Salem, A.N. (2014) Predictors of Bleeding from Esophageal Varices: The Role of Factor VII and Von Willebrand Factor (vWF). Open Journal of Gastroenterology, 4, 152-158. http://dx.doi.org/10.4236/ojgas.2014.44023
|